Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells. (Q53251883)

12 May 2018

title

Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells. (English)

1 reference

12 May 2018

1 reference

1 reference

Masato Kato

1

1 reference

12 May 2018

Yutaro Nakamura

2

1 reference

12 May 2018

Takafumi Suda

3

1 reference

12 May 2018

Yuichi Ozawa

4

1 reference

12 May 2018

Naoki Inui

5

1 reference

12 May 2018

Naohiro Seo

6

1 reference

12 May 2018

Toshi Nagata

7

1 reference

12 May 2018

Yukio Koide

8

1 reference

12 May 2018

Pawel Kalinski

9

1 reference

12 May 2018

Hirotoshi Nakamura

10

1 reference

12 May 2018

Kingo Chida

11

1 reference

12 May 2018

publication date

26 April 2011

1 reference

12 May 2018

Cancer Immunology, Immunotherapy

published in

1 reference

12 May 2018

volume

60

1 reference

12 May 2018

issue

7

1 reference

12 May 2018

page(s)

1029-1038

1 reference

12 May 2018

Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Superantigen binding to a T cell receptor beta chain of known three-dimensional structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

T-cell activation by superantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Programmed cell death and extrathymic reduction of Vβ8+CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Dendritic cells are potent antigen-presenting cells for microbial superantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Helper function of memory CD8+ T cells: heterologous CD8+ T cells support the induction of therapeutic cancer immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Dendritic cell-based therapy as a multidisciplinary approach to cancer treatment: present limitations and future scopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Alterations of immune functions in barrier disrupted skin by UVB irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Induction of protective immunity to Listeria monocytogenes with dendritic cells retrovirally transduced with a cytotoxic T lymphocyte epitope minigene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Immunization with dendritic cells loaded with alpha-galactosylceramide at priming phase, but not at boosting phase, enhances cytotoxic T lymphocyte activity against infection by intracellular bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Mucosal vaccine using CTL epitope-pulsed dendritic cell confers protection for intracellular pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

T cell-dependent maturation of dendritic cells in response to bacterial superantigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Interferon-gamma induces regression of epithelial cell carcinoma: critical roles of IRF-1 and ICSBP transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Interferon-gamma-mediated growth regulation of melanoma cells: involvement of STAT1-dependent and STAT1-independent signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Superior protective and therapeutic effects of IL-12 and IL-18 gene-transduced dendritic neuroblastoma fusion cells on liver metastasis of murine neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Comparative methodologies of regulatory T cell depletion in a murine melanoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Testing mouse mammary tumor virus superantigen as adjuvant in cytotoxic T-lymphocyte responses against a melanoma tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Individualized patient dosing in phase I clinical trials: the role of escalation with overdose control in PNU-214936.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Surface anchorage of superantigen SEA promotes induction of specific antitumor immune response by tumor-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Superantigens and their potential role in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Early expression of cytokines in lymph nodes after treatment in vivo with Staphylococcus enterotoxin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

Dendritic Cell-Based Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1015-5

10.1007/S00262-011-1015-5

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018